For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit

Cutaneous Manifestations of COVID-19 in the Inpatient Setting.

TitleCutaneous Manifestations of COVID-19 in the Inpatient Setting.
Publication TypeJournal Article
Year of Publication2021
AuthorsDo MH, Stewart CR, Harp J
JournalDermatol Clin
Date Published2021 Oct
KeywordsAdult, Chilblains, Child, COVID-19, Exanthema, Humans, Inpatients, Pityriasis Rosea, Skin Diseases, Skin Diseases, Vascular, Systemic Inflammatory Response Syndrome, Urticaria

Cutaneous findings have increasingly been reported in patients with coronavirus disease 2019 (COVID-19). This review discusses associated skin findings in patients with COVID-19 in the inpatient setting, ranging from vasculopathy-related lesions associated with high hospitalization rate and poor prognosis to inflammatory vesicular and urticarial eruptions that are rarely associated with prolonged hospitalization. We also discuss other reported COVID-19 cutaneous manifestations such as Sweet's syndrome, purpuric eruptions, and Multisystem Inflammatory Syndrome in Children. Although the relationship between dermatologic changes and COVID-19 disease progression is not fully elucidated, familiarity with cutaneous manifestations is valuable for physicians caring for patients hospitalized with COVID-19 and may help improve disease recognition and care.

Alternate JournalDermatol Clin
PubMed ID34556242
PubMed Central IDPMC8162718

Person Type: